Marketing Workplace Chronic Disease Prevention

Status Completed

Clinical Trial Summary

The objective of the project is to understand how best to help mid-size employers adopt evidence-based chronic disease prevention practices that improve employee health behaviors.

Clinical Trial Description

Employers have the incentive and the means to play a key role in chronic disease prevention. The incentive - employers need to control the costly and growing burden of chronic diseases among their employees. The means - employers purchase 94% of private health insurance, and employees spend one third of their lives in the workplace, where they often eat, move, socialize, and smoke. Over the past 5 years, the CDC and the Task Force on Community Preventive Services have recommended a number of chronic disease prevention practices. Among these, we have identified 17 practices that employers should adopt. These practices include health insurance benefits, workplace policies, and workplace programs, and aim at increasing employees' disease screening, healthy eating, influenza immunization, physical activity and tobacco cessation. Unfortunately, employer surveys reveal low adoption of these practices.

Working with the American Cancer Society, our research team from the University of Washington has developed and pilot-tested an innovative consulting intervention to increase adoption of these practices. Our two-stage intervention is comprehensive yet tailored by employer feedback.

The intervention:

- markets the "business case" that employers can help control health-care costs and productivity losses through adoption of these practices

- enables implementation by providing tools for each practice.

In this proposal, our primary aim is to test this intervention in a randomized, controlled trial among 48 medium-sized employers with a high proportion of socioeconomically disadvantaged employees in the Puget Sound area. Our primary outcome is change in employer practices as measured by survey and validated by audit and contract and policy review.

Our secondary aims include:

- development and pilot-testing of an employee-level health risk behavior survey

- cost analysis and assessment of feasibility of our intervention

- assessment of employees' preference for different message sources and message appeals.

Our multidisciplinary research team includes business, communication, and public health faculty and has more than 10 years of experience in both chronic disease prevention and working with business. If successful, our team's approach has broad applicability to other public health problems. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00452816
Study type	Interventional
Source	University of Washington
Contact
Status	Completed
Phase	N/A
Start date	April 2007
Completion date	September 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05009251` - Using Explainable AI Risk Predictions to Nudge Influenza Vaccine Uptake	N/A
Recruiting	`NCT04356924` - Psychological Treatment to Support the Consequences of Cognitive Impairment	N/A
Completed	`NCT05509049` - Precision Nudging Drives Wellness Visit Attendance at Scale	N/A
Completed	`NCT03904992` - Intervention With a Progressive Web App for the Promotion of Healthy Habits in Preschoolers	N/A
Completed	`NCT05509270` - Efficacy of Communication Modalities for Promoting Flu Shots	N/A
Completed	`NCT03167372` - Pilot Comparison of N-of-1 Trials of Light Therapy	N/A
Completed	`NCT03081520` - Affective Responses Following Aerobic Exercise With Different Intensities	N/A
Completed	`NCT05012163` - Lottery Incentive Nudges to Increase Influenza Vaccinations	N/A
Completed	`NCT03982095` - Survey on Lifestyle, Perceived Barriers and Development of Change in Patients With Prostate Cancer
Recruiting	`NCT06467058` - Convergent Validity of DABQ Questionnaire	N/A
Completed	`NCT02777086` - Sustainable HIV Risk Reduction Strategies for Probationers	N/A
Completed	`NCT02996864` - Location-based Smartphone Technology to Guide College Students Healthy Choices Ph II	N/A
Not yet recruiting	`NCT06071130` - Emotion, Aging, and Decision Making	N/A
Active, not recruiting	`NCT04152824` - Readiness Supportive Leadership Training	N/A
Active, not recruiting	`NCT05541653` - The IGNITE Study on Concentrated Investment in Black Neighborhoods	N/A
Completed	`NCT03875768` - Nourish: A Digital Health Program to Promote the DASH Eating Plan Among Adults With High Blood Pressure	N/A
Completed	`NCT04089020` - Walking to School Supports	N/A
Completed	`NCT03646903` - Reducing Help-Seeking Stigma in Young Adults at Elevated Suicide Risk	N/A
Completed	`NCT03548077` - POWERPLAY: Promoting Men's Health at Work	N/A
Recruiting	`NCT05249465` - Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.